Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Nurs Outlook. 2013 May 16;61(4):216–224.e2. doi: 10.1016/j.outlook.2013.03.007

Table 3.

Top 10 differentially expressed genes between the high and low pain groups based on p-values

Gene Symbol Genes title Function p-value Fold-Change Expression in high pain group
BATF2 basic leucine zipper transcription factor, ATF-like 2 Protein binding/protein dimerization activity 0.0002 2.064 up
CASP5 caspase 5, apoptosis-related cysteine peptidase Cysteine-type endopeptidase activity 0.0003 2.732 up
CCR1 chemokine (C-C motif) receptor 1 C-C chemokine binding/ C-C chemokine receptor activity 0.0004 2.220 up
CD69 CD69 molecule transmembraine signaling receptor activity 0.0008 4.217 up
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) molecular function/protein binding 0.0010 2.493 up
LY6E lymphocyte antigen 6 complex, locus E adrenal gland development/ epinephrine secrertion/norepinephrine metabolic process 0.0100 −2.102 down
PARP14 poly (ADP-ribose) polymerase family, member 14 NAD+ADP-ribosyltransferase activity 0.0112 −2.048 down
RPL23 ribosomal protein L23 Structoral constituent of ribosome 0.0191 −2.166 down
RPL7 ribosomal protein L7 DNA, RNA, mRNA binding/ protein homodimerization activity 0.0237 −2.869 down
SCO2 SCO2 cytochrome c oxidase assembly protein Copper ion binding 0.0312 −2.243 down
SERPING1 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 protein binding/ serine-type endopeptidase inhibitor activity 0.0316 −2.074 down
SH2D1B SH2 domain containing 1B protien binding, bridging 0.0360 −2.767 down